Edition:
India

Laboratory Corporation of America Holdings (LH.N)

LH.N on New York Stock Exchange

177.79USD
16 Feb 2018
Change (% chg)

$3.83 (+2.20%)
Prev Close
$173.96
Open
$173.68
Day's High
$179.00
Day's Low
$173.24
Volume
233,161
Avg. Vol
167,932
52-wk High
$181.65
52-wk Low
$134.49

Latest Key Developments (Source: Significant Developments)

Labcorp announces new expanded use for PD-L1 test with Bristol-Myers Squibb's Opdivo
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Laboratory Corporation Of America Holdings :Labcorp announces new expanded use for PD-L1 test with Bristol-Myers Squibb's Opdivo®.Laboratory Corporation Of America Holdings - ‍announced U.S. availability of PD-L1 ihc 28-8 pharmdx assay as complementary diagnostic for 2 indications in connection with use of Opdivo​.  Full Article

Labcorp - Co,‍ Capital Health announced that they have entered into a laboratory partnership​
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Laboratory Corporation Of America Holdings :Labcorp - Co,‍ Capital Health announced that they have entered into a laboratory partnership​.  Full Article

LabCorp reports Q3 adjusted earnings per share of $2.46
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Laboratory Corporation Of America Holdings :LabCorp announces record third quarter results and increases 2017 guidance.Q3 adjusted earnings per share $2.46.Q3 earnings per share $1.74.Q3 revenue $2.6 billion versus I/B/E/S view $2.55 billion.Q3 earnings per share view $2.39 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $9.40 to $9.60.LabCorp - ‍backlog for covance drug development at end of quarter was $6.84 billion, which includes backlog from Chiltern acquisition of $1.0 billion ​.LabCorp - ‍expects approximately $2.7 billion of backlog in covance drug development to convert into revenue in next twelve months​.LabCorp - ‍sees 2017 free cash flow increased to $970 million to $1,010 million, up 8% to 13% over 2016​.LabCorp sees ‍for 2017 net revenue growth of 8.0% to 8.5% over 2016 net revenue of $9.44 billion​.FY2017 earnings per share view $9.50, revenue view $10.10 billion -- Thomson Reuters I/B/E/S.LabCorp says "‍revenue growth" in quarter "was negatively impacted by approximately 0.7% due to multiple hurricanes during quarter​".  Full Article

Walgreens, Labcorp collaborate to bring patient service centers for laboratory testing to select Walgreens stores
Thursday, 29 Jun 2017 

June 28 (Reuters) - Walgreens Boots Alliance Inc: :Walgreens and Labcorp collaborate to bring patient service centers for laboratory testing to select Walgreens stores.Walgreens Boots Alliance Inc - seven service centers planned to open at Walgreens stores in 2017.  Full Article

Shore Capital Partners announces sale of Clearpath Diagnostics to LabCorp
Tuesday, 4 Oct 2016 

Shore Capital Partners: Shore Capital Partners announces sale of Clearpath Diagnostics .Terms of transaction were not disclosed.  Full Article

Oxford Immunotec announces favorable recommendation by the magistrate judge
Thursday, 1 Sep 2016 

Oxford Immunotec Global PLC : Oxford Immunotec announces favorable recommendation by the magistrate judge in patent infringement litigation . Says recommendation denying in substantial part defendants' motion to dismiss company's claims . Patent infringement lawsuit against Qiagen Inc, Quest Diagnostics Inc and Laboratory Corporation of America Holdings .Says recommendation should now "allow company to press forward with its case against three defendants".  Full Article

Labcorp's acquisition of Sequenom clears antitrust review
Tuesday, 23 Aug 2016 

Laboratory Corporation Of America Holdings : Labcorp's acquisition of Sequenom clears antitrust review .Scott-Rodino antitrust improvements act of 1976 applicable to acquisition of Sequenom Inc by co has expired.  Full Article

Labcorp to acquire Sequenom
Wednesday, 27 Jul 2016 

Laboratory Corporation Of America Holdings : Labcorp announces agreement to acquire sequenom . Deal for an equity value of $302 million . Deal for an equity value of $302 million . Would acquire all of outstanding shares of sequenom in a cash tender offer for $2.40 per share . Labcorp announces agreement to acquire sequenom . Deal has total enterprise value of approximately $371 million . Deal has total enterprise value of approximately $371 million, including net indebtedness . Says board of directors of sequenom, having determined that offer and merger are advisable . Jp morgan is acting as financial advisor to sequenom in connection with transaction, and cooley llp is providing legal advice .Says barclays is acting as financial advisor to labcorp, and hogan lovells is providing legal advice.  Full Article

LabCorp reports Q2 adjusted earnings per share of $2.31
Wednesday, 27 Jul 2016 

Laboratory Corporation Of America Holdings : Laboratory corporation of america holdings says raises 2016 guidance . Sees 2016 net revenue growth of 9.5% to 10.5% over 2015 . Sees 2016 net revenue growth in labcorp diagnostics of 4.5 percent to 5.5 percent . Laboratory corporation of america® holdings announces 2016 second quarter results and raises 2016 guidance . Q2 adjusted earnings per share $2.31 . Q2 earnings per share $1.91 . Q2 revenue $2.4 billion versus i/b/e/s view $2.33 billion . Q2 earnings per share view $2.30 -- Thomson Reuters I/B/E/S . Sees fy 2016 adjusted earnings per share $8.60 to $8.95 . Sees 2016 free cash flow (operating cash flow less capital expenditures) of $900 million to $950 million . Fy2016 earnings per share view $8.79, revenue view $9.35 billion -- Thomson Reuters I/B/E/S . Laboratory corporation of america holdings sees 2016 net revenue growth of 9.5% to 10.5% .Laboratory corporation of america holdings says organic revenue growth in quarter, excluding currency, was 6.4%.  Full Article

LabCorp announces availability of the Realstar Zika virus test
Monday, 6 Jun 2016 

Laboratory Corporation Of America Holdings : LabCorp announces the availability of the Realstar Zika virus test .Altona Diagnostics' Realstar Zika virus RT-PCR kit U.S. has received FDA emergency use authorization.  Full Article